Showing results (361-370 of 375) with videos related to

Sort By:
Pageof 38
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2012
Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brainPaolo Zanotti-Fregonara, Vanessa N Barth, Jeih-San Liow, et al.
ACS Chemical Neuroscience|March 28, 2020
Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4DYuichi Wakabayashi, Sanjay Telu, Rachel M Dick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2018
Evaluation of a PET Radioligand to Image Soumen Paul, Mohammad B Haskali, Jeih-San Liow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
Evaluation of [<sup>18</sup>F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brainBing Li, Palak Wadhwa, Walter Lerchner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2024
PET imaging in rat brain shows opposite effects of acute and chronic alcohol exposure on phosphodiesterase-4B, an indirect biomarker of cAMP activityShiyu Tang, Sung Won Kim, Amanda Olsen-Dufour, et al.
Biological Psychiatry|October 4, 2002
Developing novel treatments for mood disorders: accelerating discoveryCarol A Tamminga, Charles B Nemeroff, Randy D Blakely, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
PET Quantification in Healthy Humans of Cyclooxygenase-2, a Potential Biomarker of NeuroinflammationXuefeng Yan, Martin Noergaard, Cheryl L Morse, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2018
Influence of alcoholism and cholesterol on TSPO binding in brain: PET [<sup>11</sup>C]PBR28 studies in humans and rodentsSung Won Kim, Corinde E Wiers, Ryan Tyler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2022
First-in-Human Evaluation of <sup>18</sup>F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4BYuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, et al.
Journal of Neuroinflammation|May 4, 2020
PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human studyStal Shrestha, Min-Jeong Kim, Mark Eldridge, et al.
Pageof 38